Albert A Antolin

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 14

Top Venues

Nucleic acids research

Expert opinion on drug discovery

RSC medicinal chemistry

Circulation. Genomic and precision medicine

Institute of Cancer Research Division of Cancer Therapeutics

Universitat Pompeu Fabra (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institute of Cancer Research Division of Cancer Therapeutics Jan 01 2015

United Kingdom

Sir Henry Wellcome Fellow :: Data Science

Education History

Universitat Pompeu Fabra Sep 01 2009 - Oct 14 2014

Spain

PHD :: Experimental and Health Sciences

Universitat Ramon Llull Oct 01 2002 - Jun 15 2007

Spain

MSC :: Organic Chemistry

Publications

Leticia Manen-Freixa, Albert A Antolin
Polypharmacology prediction: the long road toward comprehensively anticipating small-molecule selectivity to de-risk drug discovery. Expert opinion on drug discovery (2024)
Patrizio Di Micco, Albert A Antolin, Costas Mitsopoulos, Eloy Villasclaras-Fernandez, Domenico Sanfelice, Daniela Dolciami, Pradeep Ramagiri, Ioan L Mica, Joseph E Tym, Philip W Gingrich, Huabin Hu, Paul Workman, Bissan Al-Lazikani
canSAR: update to the cancer translational research and drug discovery knowledgebase. Nucleic acids research 51 (D1) (2023)
Suzanne Ackloo, Albert A Antolin, Jose Manuel Bartolome, Hartmut Beck, Alex N Bullock, Ulrich A K Betz, Jark Böttcher, Peter J Brown, Menorca Chaturvedi, Alisa Crisp, Danette L Daniels, Jan Dreher, Kristina Edfeldt, Aled Morgan Edwards, Ursula Egner, Jon Elkins, Christian Fischer, Tine Glendorf, Steven Goldberg, Ingo V Hartung, Alexander Hillisch, Evert J Homan, Stefan Knapp, Markus Köster, Oliver Krämer, Josep Llaveria, Uta Lessel, Sven Lindemann, Lars Linderoth, Hisanori Matsui, Maurice Michel, Florian Montel, Anke Mueller-Fahrnow, Susanne Müller, Dafydd R Owen, Kumar Singh Saikatendu, Vijayaratnam Santhakumar, Wendy Sanderson, Cora Scholten, Matthieu Schapira, Sujata Sharma, Brock Shireman, Michael Sundström, Matthew H Todd, Claudia Tredup, Jennifer Venable, Timothy M Willson, Cheryl H Arrowsmith
Target 2035 - an update on private sector contributions. RSC medicinal chemistry 14 (6) (2023)
Suzanne Ackloo, Albert A Antolin, Jose Manuel Bartolome, Hartmut Beck, Alex N Bullock, Ulrich A K Betz, Jark Böttcher, Peter J Brown, Menorca Chaturvedi, Alisa Crisp, Danette L Daniels, Jan Dreher, Kristina Edfeldt, Aled Morgan Edwards, Ursula Egner, Jon Elkins, Christian Fischer, Tine Glendorf, Steven Goldberg, Ingo V Hartung, Alexander Hillisch, Evert J Homan, Stefan Knapp, Markus Köster, Oliver Krämer, Josep Llaveria, Uta Lessel, Sven Lindemann, Lars Linderoth, Hisanori Matsui, Maurice Michel, Florian Montel, Anke Mueller-Fahrnow, Susanne Müller, Dafydd R Owen, Kumar Singh Saikatendu, Vijayaratnam Santhakumar, Wendy Sanderson, Cora Scholten, Matthieu Schapira, Sujata Sharma, Brock Shireman, Michael Sundström, Matthew H Todd, Claudia Tredup, Jennifer Venable, Timothy M Willson, Cheryl H Arrowsmith
Target 2035 - an update on private sector contributions. RSC medicinal chemistry 14 (6) (2023)
Patrizio Di Micco, Albert A Antolin, Costas Mitsopoulos, Eloy Villasclaras-Fernandez, Domenico Sanfelice, Daniela Dolciami, Pradeep Ramagiri, Ioan L Mica, Joseph E Tym, Philip W Gingrich, Huabin Hu, Paul Workman, Bissan Al-Lazikani
canSAR: update to the cancer translational research and drug discovery knowledgebase. Nucleic acids research 51 (D1) (2023)
Patrizio Di Micco, Albert A Antolin, Costas Mitsopoulos, Eloy Villasclaras-Fernandez, Domenico Sanfelice, Daniela Dolciami, Pradeep Ramagiri, Ioan L Mica, Joseph E Tym, Philip W Gingrich, Huabin Hu, Paul Workman, Bissan Al-Lazikani
canSAR: update to the cancer translational research and drug discovery knowledgebase. Nucleic acids research 51 (D1) (2023)
Albert A Antolin, Domenico Sanfelice, Alisa Crisp, Eloy Villasclaras Fernandez, Ioan L Mica, Yi Chen, Ian Collins, Aled Edwards, Susanne Müller, Bissan Al-Lazikani, Paul Workman
The Chemical Probes Portal: an expert review-based public resource to empower chemical probe assessment, selection and use. Nucleic acids research (2022)
Belinda Gray, Alban-Elouen Baruteau, Albert A Antolin, Alan M Pittman, Giselle Sarganas Margolis, Mariam Molokhia, Marieke T Blom, Rachel Bastiaenen, Abdenasser Bardai, Silvia Giuliana Priori, Carlo Napolitano, Peter E Weeke, Saad A Shakir, Wilhelm Haverkamp, Jordi Mestres, Bo Gregers Winkel, Adam A Witney, Irina Chis Ster, Ajanthah Sangaralingam, Alan John Camm, Jacob Tfelt Hansen, Dan M Roden, Hanno L Tan, Edeltraut Garbe, Miriam C J M Sturkenboom, Elijah R Behr
Rare Variation in Drug Metabolism and Long QT Genes and the Genetic Susceptibility to Acquired Long QT Syndrome. Circulation. Genomic and precision medicine 15 (1) (2022)
Albert A Antolin, Marta Cascante
AI delivers Michaelis constants as fuel for genome-scale metabolic models. PLoS biology 19 (10) (2021)
Daranjit Sandhu, Albert A Antolin, Anthony Richard Cox, Alan M Jones
Identification of different side effects between PARP inhibitors and their polypharmacological multi-target rationale. British journal of clinical pharmacology (2021)
Albert A Antolin, Malaka Ameratunga, Udai Banerji, Paul Andrew Clarke, Paul Workman, Bissan Al-Lazikani
The kinase polypharmacology landscape of clinical PARP inhibitors. Scientific reports 10 (1) (2020)
Albert A Antolin, Paul Workman, Bissan Al-Lazikani
Public resources for chemical probes: the journey so far and the road ahead. Future medicinal chemistry 13 (8) (2019)
Paul Workman, Albert A Antolin, Bissan Al-Lazikani
Transforming cancer drug discovery with Big Data and AI. Expert opinion on drug discovery 14 (11) (2019)
Florian Mayerthaler, Michael F Finley, Tom A Pfeifer, Albert A Antolin
Meeting Proceedings from ICBS 2018- Toward Translational Impact. ACS chemical biology 14 (4) (2019)

Albert A Antolin.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Albert A Antolin